These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4666676)

  • 1. 4:4 diacetyl-diamino-diphenyl sulphone in the treatment of leprosy.
    Kundu S; Ghosh S
    Bull Calcutta Sch Trop Med; 1972 Apr; 20(2):30-1. PubMed ID: 4666676
    [No Abstract]   [Full Text] [Related]  

  • 2. Acedapsone in leprosy treatment: trial in 68 active cases in Micronesia.
    Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):48-52. PubMed ID: 4672994
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with 4,4'-diacetyldiaminodiphenylsulfone (DADDS) of leprosy patients in the Karimui, New Guinea.
    Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
    Am J Trop Med Hyg; 1971 May; 20(3):495-501. PubMed ID: 4932529
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy of leprosy.
    Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; Martínez Domínguez V
    Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of sulphone resistant leprosy--a review of sixty one cases.
    Seshadri PS; Ravi NT
    Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123
    [No Abstract]   [Full Text] [Related]  

  • 6. Acedapsone in leprosy chemoprophylaxis: field trial in three high-prevalence villages in Micronesia.
    Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):40-7. PubMed ID: 4672993
    [No Abstract]   [Full Text] [Related]  

  • 7. Length of continued treatment of an inactive case of leprosy.
    Dharmendra
    Lepr India; 1976 Jul; 48(3):212-6. PubMed ID: 1022967
    [No Abstract]   [Full Text] [Related]  

  • 8. Acid phosphatase activity of liver homogenates and its relation to drug activity in rats infected with Mycobacterium lepraemurium.
    Mathur IS; Gupta SK
    Int J Lepr Other Mycobact Dis; 1970; 38(3):264-70. PubMed ID: 5533689
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histological and bacteriological changes in lepromatous leprosy after treatment with diamino-diphenyl-sulfone (sulfone mère)].
    NICOLAU SG; VULCAN P
    Arch Klin Exp Dermatol; 1958; 207(5):486-98. PubMed ID: 13595786
    [No Abstract]   [Full Text] [Related]  

  • 10. [In vitro immunologic changes in 4 patients with lepromatous leprosy treated for 1 year with rifampicin and sulfones and left untreated the following year].
    Saint-André P
    Acta Leprol; 1979; (76-77):301-2. PubMed ID: 121849
    [No Abstract]   [Full Text] [Related]  

  • 11. [The 4:4 '-diamino diphenyl sulfone in the treatment of lepromatous leprosy].
    DUARTE LG; DE MELLO PH
    Rev Bras Leprol; 1953 Sep; 21(3):207-20. PubMed ID: 13167563
    [No Abstract]   [Full Text] [Related]  

  • 12. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
    Ji B
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Sulphone resistance in leprosy.
    Crawford CL
    Lancet; 1975 Aug; 2(7928):280. PubMed ID: 49828
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of leprosy].
    Merklen FP; Cottenot F
    Therapeutique; 1973 Apr; 49(4):267-8. PubMed ID: 4775220
    [No Abstract]   [Full Text] [Related]  

  • 15. Single-dose treatment for single lesion leprosy; histopathological observations.
    Shinde A; Khopkar U; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):328-30. PubMed ID: 11221099
    [No Abstract]   [Full Text] [Related]  

  • 16. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

  • 17. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR; Pai VV; Samy MS; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract]   [Full Text] [Related]  

  • 18. Leprosy under treatment with diamino-diphenyl sulphone (two cases).
    WADDINGTON E
    Proc R Soc Med; 1951 Aug; 44(8):681-2. PubMed ID: 14864570
    [No Abstract]   [Full Text] [Related]  

  • 19. The rate of relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy.
    Waters MF; Rees RJ; Laing AB; Khoo Kah Fah ; Meade TW; Parikshak N; North WR
    Lepr Rev; 1986 Jun; 57(2):101-9. PubMed ID: 3747702
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of the derivatives of diamino-diphenyl sulphone in leprosy. A guide.
    ROY AT
    Antiseptic; 1951 Jan; 48(1):9-12. PubMed ID: 14820036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.